Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharmacopeia, Inc. (ACCL) (Prev: PCOP) -- Ignore unavailable to you. Want to Upgrade?

To: Dr. Voodoo who wrote (56)	2/6/1998 2:26:00 PM
From: Susan Rodney	Respond to of 179

Hi gang, I responded to you guys yesterday but for some reason I don't see it posted on the thread. Sorry about that. We are really excited about our proposed acquisition of MSI. It seems like you have identified the important issues. As Dr. Voodoo points out, the litigious society in which we live prohibits me from writing a lot about the rationale etc. But you can feel free to listen to the conference call our CEO had with investors yesterday morning. It will only be available until the end of today, so listen quickly. The number is 800/633-8284 and the reservation # is 3833367. If you don't get to listen in time, please call/email me ((609) 452-3643/srodney@pharmacop.com) and I'll provide you a written transcript. It looks like you got accurate financial information on MSI. For additional information, go to the EDGAR database of the SEC and pull their S-1 filing from their IPO last year (the IPO was never consummated). It should be dated back to the beginning of 1997. Also, as for the financial impact on Pharmacopeia once the acquisition is complete, I can only tell you what our analysts are projecting. They are looking for a loss of $0.01 this year, compared to their previous estimates of a loss of $0.50. For 1999, they are projecting a gain of $0.45 compared to a gain of $0.02. So you can see that it is projected to dramatically improve our profitability. Hope this helps. I don't know if you guys saw but this proposed merger was written up in the New York Times, Wall Street Journal, BioWorld, BioCentury, many local paper, both here and in San Diego and mentioned on CNN and CNBC. Everything I've read and heard from investors has been overwhelmingly positive. We're really excited about it. Talk to you soon. Sue